What you need to know:
– proofreada leading provider of clinician-led, values-based obesity treatment programs, today announced the appointment of Rob McNaughton as its new Chief Executive Officer.
– MacNaughton’s leadership and Calibrate’s strategic direction under the OptumRx partnership will position the company to achieve significant growth and positively impact both the personal and enterprise healthcare environments.
Mr. McNaughton has an outstanding track record of launching new healthcare ventures, overseeing product development, and scaling businesses. Prior to joining Calibrate, MacNaughton served as Venture Chair at Redesign Health, where he oversaw the launch and growth of several healthcare delivery and technology brands. His previous positions include his CEO position at Curve Health and Nurse Grid, and his chief product officer at Campia Health Solutions, a multi-state Blue Cross Blue Shield payer.
“Obesity is the largest category of chronic disease and one of the largest drivers of health care spending. Companies at the forefront of value-based obesity care, helping employers and insurers manage rising costs. However, we are honored to join a company that is clearly committed to tackling this epidemic head-on,” said Rob McNaughton, CEO of Calibrate. “Our commercial momentum is stronger than ever and we are confident we will continue to collaborate with industry leaders to deliver sustainable best-in-class results.”